نتایج جستجو برای: heart failure plasma bnp pediatrics

تعداد نتایج: 973985  

Journal: :Acta medica Indonesiana 2009
Frans Ferdinal Franciscus D Suyatna Septelia Inawati Wanandi Mohamad Sadikin

AIM To investigate the expression of B-type natriuretic peptide-45 (BNP-45) gene which was induced by systemic chronic hypoxia, and whether these changes would be different from BNP-45 protein in the plasma and its mRNA in the ventricular myocardial. This study also aimed to test the hypothesis that systemic chronic hypoxia may cause heart failure. METHODS Although clinical use of BNP as a bi...

Journal: :Clinical science 2005
Cathrine Wold Knudsen Harald Vik-Mo Torbjørn Omland

BNP (B-type natriuretic peptide) and anaemia are both associated with adverse outcome in patients with chronic heart failure. Whether low haemoglobin levels are independently predictive of elevated BNP levels in subjects without heart failure is unknown. In the present study, we examined the relationship between haemoglobin and BNP levels in 234 patients with suspected coronary heart disease wi...

2017
Yasuaki Nakagawa Toshio Nishikimi Koichiro Kuwahara Aoi Fujishima Shogo Oka Takayoshi Tsutamoto Hideyuki Kinoshita Kazuhiro Nakao Kosai Cho Hideaki Inazumi Hiroyuki Okamoto Motohiro Nishida Takao Kato Hiroyuki Fukushima Jun K. Yamashita Wino J. Wijnen Esther E. Creemers Kenji Kangawa Naoto Minamino Kazuwa Nakao Takeshi Kimura

BACKGROUND Recent studies have shown that plasma levels of the biologically inactive prohormone for brain natriuretic peptide (proBNP) are increased in patients with heart failure. This can contribute to a reduction in the effectiveness of circulating BNP and exacerbate heart failure progression. The precise mechanisms governing the increase in proBNP remain unclear, however. METHODS AND RESU...

Journal: :Circulation 2003
A Mark Richards M Gary Nicholls Eric A Espiner John G Lainchbury Richard W Troughton John Elliott Christopher Frampton John Turner Ian G Crozier Timothy G Yandle

BACKGROUND A recent landmark report has demonstrated that plasma B-type natriuretic peptide (BNP) measured in acute coronary syndromes independently predicts mortality, heart failure, and new myocardial infarction. After acute cardiac injury, left ventricular ejection fraction (LVEF) is also of prognostic significance and plays a major role in determining the therapeutic response. METHODS AND...

2016
A. Mark Richards

OBJECTIVES We sought to assess plasma concentrations of the amino (N)-terminal portion of pro-brain natriuretic peptide (N-BNP) and adrenomedullin for prediction of adverse outcomes and responses to treatment in 297 patients with ischemic left ventricular (LV) dysfunction who were randomly assigned to receive carvedilol or placebo. BACKGROUND Although neurohormonal status has known prognostic s...

2017
Sachiko Bando Takeshi Soeki Tomomi Matsuura Takeshi Tobiume Takayuki Ise Kenya Kusunose Koji Yamaguchi Shusuke Yagi Daiju Fukuda Takashi Iwase Hirotsugu Yamada Tetsuzo Wakatsuki Michio Shimabukuro Naoki Muguruma Tetsuji Takayama Ichiro Kishimoto Kenji Kangawa Masataka Sata

BACKGROUND Natriuretic peptides have been proposed as biomarkers of cardiovascular disease, especially heart failure. Brain natriuretic peptide (BNP) has also been shown to be upregulated at the transcriptional and translational levels by pro-inflammatory cytokines in cardiac myocytes. Although we often measure plasma BNP levels in cancer patients, it remains unknown whether cancer-related infl...

Journal: :Circulation 2004
Barry J Maron Venkatakrishna N Tholakanahalli Andrey G Zenovich Susan A Casey Daniel Duprez Dorothee M Aeppli Jay N Cohn

BACKGROUND Hypertrophic cardiomyopathy (HCM) has a diverse clinical spectrum that often includes progressive heart failure symptoms and disability. Assessment of symptom severity may be highly subjective, encumbered by the heterogeneous clinical presentation. Plasma B-type natriuretic peptide (BNP) has been used widely as an objective marker for heart failure severity and outcome, predominantly...

Journal: :Clinical science 2004
Iain B Squire Russell J O'Brien Bettina Demme Joan E Davies Leong L Ng

Elevated plasma natriuretic peptide levels after AMI (acute myocardial infarction) are associated with adverse outcome. The aim of the present study was to examine the relationship of plasma N-ANP (N-terminal pro-atrial natriuretic peptide) and N-BNP (N-terminal pro-B-type natriuretic peptide) with mortality and heart failure following AMI. We studied 403 patients with AMI. Blood was sampled fo...

Journal: :Journal of the American College of Cardiology 2007
Faquan Liang Jessica O'Rear Ute Schellenberger Lungkuo Tai Michael Lasecki George F Schreiner Fred S Apple Alan S Maisel N Stephen Pollitt Andrew A Protter

OBJECTIVES These studies describe molecular forms of circulating B-type natriuretic peptide (BNP) as well as their biological activity. BACKGROUND Increased circulating levels of immunoreactive BNP correlate with the severity of heart failure and are considered a sensitive biomarker. However, little is known about the molecular forms of circulating BNP and their biological activity. METHODS...

Journal: :European heart journal 2003
M R Cowie P Jourdain A Maisel U Dahlstrom F Follath R Isnard A Luchner T McDonagh J Mair M Nieminen G Francis

Many claims have been made in recent years regarding the utility of plasma B-type natriuretic peptide (BNP) concentration measurements in the diagnosis, risk stratification and monitoring of patients with heart failure. This paper summarizes the current evidence and provides guidance for practising clinicians. Overall, plasma BNP testing appears to be of most value in the diagnostic arena, wher...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید